Improving Therapeutic Learning in Depression: Proof of Concept
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Despite advances in both pharmacotherapy and psychotherapy for major depression, non-response
and partial-response remain relatively common outcomes, motivating the search for new
treatments. This study is concerned with the development of one such novel treatment, the
augmentation of exposure-based cognitive-behavior therapy (CBT) with d-cycloserine (DCS).
Phase:
Phase 2
Details
Lead Sponsor:
Boston University Boston University Charles River Campus